Keywords: BioDiem, NasoVac, Serum Institute of India, Merck & Co, Nobilon, India

BioDiem’s live attenuated flu vaccine NasoVac launched in India

Article | 12 July 2010

Print This

Australian firm BioDiem’s lead product, the live attenuated influenza vaccine (LAIV) has been granted regulatory approval for marketing in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in